Patents by Inventor Eva Akerblom

Eva Akerblom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070276133
    Abstract: Antibody specific for a 5-HTOL compound. A glucuronide with 5-hydroxytryptophol (5-HTOL) characterized in that it comprises the structure of the ?-glucuronide between the 5-hydroxy group of 5-HTOL and D-glucopyranosiduronic acid. An immunoassay and a diagnostic method utilizing the immunoassay wherein a 5-hydroxytryptophol (5-HTOL) compound is determined by the use of an antibody specific for a 5-HTOL compound is used.
    Type: Application
    Filed: January 3, 2007
    Publication date: November 29, 2007
    Applicant: Axis Biochemicals ASA
    Inventors: Ragnhild Brandt, Olof Beck, Anders Helander, Rose-Marie Jonsson, Eric Unger, Stefan Borg, Eva Akerblom
  • Publication number: 20060100420
    Abstract: Antibody specific for a 5-HTOL compound. A glucuronide with 5-hydroxytryptophol (5-HTOL) characterized in that it comprises the structure of the ?-glucuronide between the 5-hydroxy group of 5-HTOL and D-glucopyranosiduronic acid. An immunoassay and a diagnostic method utilizing the immunoassay wherein a 5-hydroxytryptophol (5-HTOL) compound is determined by the use of an antibody specific for a 5-HTOL compound is used.
    Type: Application
    Filed: April 23, 2003
    Publication date: May 11, 2006
    Inventors: Ragnhild Brandt, Olof Beck, Anders Helander, Rose-Marie Jonsson, Eric Unger, Stefan Borg, Eva Akerblom
  • Patent number: 6608178
    Abstract: Antibody specific for a 5-HTOL compound. A glucuronide with 5-hydroxytryptophol (5-HTOL) characterized in that it comprises the structure of the &bgr;-glucuronide between the 5-hydroxy group of 5-HTOL and D-glucopyranosiduronic acid. An immunoassay and a diagnostic method utilizing the ummunoassay wherein a 5-hydroxytryptophol (5-HTOL) compound is determined by the use of an antibody specific for a 5-HTOL compound is used.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: August 19, 2003
    Assignee: Alco Dia A.B.
    Inventors: Ragnhild Brandt, Olof Beck, Anders Helander, Rose-Marie Jonsson, Eric Unger, Stefan Borg, Eva Akerblom
  • Patent number: 5858363
    Abstract: A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regime for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 12, 1999
    Assignee: Pharmacia & Upjohn AB
    Inventors: Mikael Dohlsten, Eva Akerblom, Gunnar Hedlund, Peter A. Lando